Apyx Medical will release third-quarter financial results on November 6, followed by a conference call for discussion.
Quiver AI Summary
Apyx Medical Corporation announced that it will release its financial results for the third quarter of fiscal year 2025 on November 6th before the market opens. Following the release, management will host a conference call at 8:00 a.m. Eastern Time to discuss the results and engage in a question-and-answer session. Interested participants can join the call by phone or via a live webcast, which will also be archived on the company's website. Apyx Medical specializes in advanced energy technology for cosmetic and surgical applications, including its Renuvion and AYON Body Contouring System, supported by extensive clinical research.
Potential Positives
- Apyx Medical is set to release third quarter financial results, indicating transparency and commitment to keeping investors informed.
- The upcoming conference call will provide a platform for direct communication between management and investors, fostering trust and engagement.
- The company continues to highlight its innovative product offerings in the cosmetic and surgical markets, suggesting ongoing development and potential for growth.
- Apyx Medical's technologies, Renuvion and J-Plasma, are supported by over 90 clinical publications, showcasing a strong evidence base for their effectiveness and credibility in the medical community.
Potential Negatives
- Announcement of financial results release may imply ongoing scrutiny of the company's performance and financial health, which could be a concern for investors.
- The need to hold a Q&A session indicates potential investor uncertainty about past performance or future outlook.
- Despite innovative technology claims, the reliance on external OEM agreements could raise questions regarding the company's long-term sustainability and independence.
FAQ
When will Apyx Medical release its third quarter financial results?
Apyx Medical will release its financial results for the third quarter on November 6, 2025, before markets open.
What time is the Apyx Medical conference call?
The conference call will take place at 8:00 a.m. Eastern Time on November 6, 2025.
How can I access the Apyx Medical earnings call?
To access the earnings call, dial 800-717-1738, or 646-307-1865 for international calls, and use access code 73607.
Is there a webcast for the Apyx Medical conference call?
Yes, a live webcast of the call can be accessed via the Apyx Medical Earnings Webcast link and the Investor Relations section of the website.
What products does Apyx Medical manufacture?
Apyx Medical manufactures Renuvion®, the AYON Body Contouring System™, and J-Plasma® for cosmetic and surgical markets.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$APYX Hedge Fund Activity
We have seen 13 institutional investors add shares of $APYX stock to their portfolio, and 20 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- RATHBONES GROUP PLC removed 101,334 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $228,001
- WEALTH ENHANCEMENT ADVISORY SERVICES, LLC removed 90,750 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $204,187
- SILVERBERG BERNSTEIN CAPITAL MANAGEMENT LLC added 89,767 shares (+10.0%) to their portfolio in Q3 2025, for an estimated $192,101
- ROYCE & ASSOCIATES LP removed 85,764 shares (-3.4%) from their portfolio in Q2 2025, for an estimated $192,969
- NANTAHALA CAPITAL MANAGEMENT, LLC added 80,000 shares (+2.5%) to their portfolio in Q2 2025, for an estimated $180,000
- SALEM INVESTMENT COUNSELORS INC added 45,500 shares (+inf%) to their portfolio in Q3 2025, for an estimated $97,370
- BRIDGEWAY CAPITAL MANAGEMENT, LLC removed 30,000 shares (-32.8%) from their portfolio in Q2 2025, for an estimated $67,500
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
CLEARWATER, Fla., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ: APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion ® and the AYON Body Contouring System™, today announced that financial results for the third quarter of fiscal year 2025 will be released before markets open on Thursday, November 6th.
Management will host a conference call at 8:00 a.m. Eastern Time on Thursday, November 6 th , to discuss the results of the quarter, and to host a question-and-answer session. To listen to the call by phone, interested parties may dial 800-717-1738 (or 646-307-1865 for international callers) and provide access code 73607. Participants should ask for the “Apyx Medical Corporation Call”. A live webcast of the call will be accessible via the following link: Apyx Medical Earnings Webcast and via the Investor Relations section of the Company’s website, where it will also be archived for future reference.
Investor Relations Contact:
Jeremy Feffer
Managing Director
LifeSci Advisors
OP: 212-915-2568
[email protected]
About Apyx Medical Corporation:
Apyx Medical Corporation is an advanced energy technology company with a passion for elevating people’s lives through innovative products, including its Helium Plasma Platform Technology products marketed and sold as Renuvion
®
and now the AYON Body Contouring System™ in the cosmetic surgery market and J-Plasma
®
in the hospital surgical market. Renuvion and J-Plasma offer surgeons a unique ability to provide controlled heat to tissue to achieve their desired results. The effectiveness of Renuvion and J-Plasma are supported by more than 90 clinical publications. The Company also leverages its deep expertise and decades of experience in unique waveforms through OEM agreements with other medical device manufacturers. For further information about the Company and its products, please refer to the Apyx Medical Corporation website at
www.ApyxMedical.com
